CACNA1D and breast carcinoma: Estrogen significantly upregulated LTCC CaV1.3 protein expression in a dose and time-dependent manner in the MCF-7 luminal-type ER-positive breast cancer cell line which was suppressed upon treatment with GPCR antagonist PTX revealing a non-genomic mechanism of action of estrogen in breast cancer [185].